Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer

Natural killer (NK) cell activity is influenced by a complex integration of signaling pathways activated downstream of both activating and inhibitory surface receptors. The tumor microenvironment can suppress NK cell activity, and there is a great clinical interest in understanding whether modulatin...

Full description

Saved in:
Bibliographic Details
Main Authors: Bin Han, Fang-yuan Mao, Yong-liang Zhao, Yi-pin Lv, Yong-sheng Teng, Mubing Duan, Weisan Chen, Ping Cheng, Ting-ting Wang, Zhong-yuan Liang, Jin-yu Zhang, Yu-gang Liu, Gang Guo, Quan-ming Zou, Yuan Zhuang, Liu-sheng Peng
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/6248590
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554656200392704
author Bin Han
Fang-yuan Mao
Yong-liang Zhao
Yi-pin Lv
Yong-sheng Teng
Mubing Duan
Weisan Chen
Ping Cheng
Ting-ting Wang
Zhong-yuan Liang
Jin-yu Zhang
Yu-gang Liu
Gang Guo
Quan-ming Zou
Yuan Zhuang
Liu-sheng Peng
author_facet Bin Han
Fang-yuan Mao
Yong-liang Zhao
Yi-pin Lv
Yong-sheng Teng
Mubing Duan
Weisan Chen
Ping Cheng
Ting-ting Wang
Zhong-yuan Liang
Jin-yu Zhang
Yu-gang Liu
Gang Guo
Quan-ming Zou
Yuan Zhuang
Liu-sheng Peng
author_sort Bin Han
collection DOAJ
description Natural killer (NK) cell activity is influenced by a complex integration of signaling pathways activated downstream of both activating and inhibitory surface receptors. The tumor microenvironment can suppress NK cell activity, and there is a great clinical interest in understanding whether modulating tumor-mediated NK cell suppression and/or boosting preexisting NK cell numbers in cancer patients is therapeutically viable. To this light, we characterized the surface receptor phenotypes of peripheral blood NK cells and examined their clinical relevance to human gastric cancer (GC). We found that the proportion of peripheral blood NK cells which expressed the activating receptors NKp30, NKp46, NKG2D, and DNAM-1 was significantly decreased in GC patients compared to healthy donors, and that this decrease was positively associated with tumor progression. At the same time, plasma TGF-β1 concentrations were significantly increased in GC patients and negatively correlated with the proportion of NKp30, NKp46, NKG2D, and DNAM-1 expressing NK cells. Furthermore, TGF-β1 significantly downregulated the expression of NKp30, NKp46, NKG2D, and DNAM-1 on NK cells in vitro, and the addition of galunisertib, an inhibitor of the TGF-β receptor subunit I, reversed this downregulation. Altogether, our data suggest that the decreased expression of activating receptors NKp30, NKp46, NKG2D, and DNAM-1 on peripheral blood NK cells is positively associated with GC progression, and that TGF-β1-mediated NK cell suppression may be a therapeutically targetable characteristic of GC.
format Article
id doaj-art-b34ac744ccf8477da76410edb5c91e13
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-b34ac744ccf8477da76410edb5c91e132025-02-03T05:50:53ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/62485906248590Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric CancerBin Han0Fang-yuan Mao1Yong-liang Zhao2Yi-pin Lv3Yong-sheng Teng4Mubing Duan5Weisan Chen6Ping Cheng7Ting-ting Wang8Zhong-yuan Liang9Jin-yu Zhang10Yu-gang Liu11Gang Guo12Quan-ming Zou13Yuan Zhuang14Liu-sheng Peng15Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province 637000, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaLa Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3085, AustraliaLa Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3085, AustraliaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNatural killer (NK) cell activity is influenced by a complex integration of signaling pathways activated downstream of both activating and inhibitory surface receptors. The tumor microenvironment can suppress NK cell activity, and there is a great clinical interest in understanding whether modulating tumor-mediated NK cell suppression and/or boosting preexisting NK cell numbers in cancer patients is therapeutically viable. To this light, we characterized the surface receptor phenotypes of peripheral blood NK cells and examined their clinical relevance to human gastric cancer (GC). We found that the proportion of peripheral blood NK cells which expressed the activating receptors NKp30, NKp46, NKG2D, and DNAM-1 was significantly decreased in GC patients compared to healthy donors, and that this decrease was positively associated with tumor progression. At the same time, plasma TGF-β1 concentrations were significantly increased in GC patients and negatively correlated with the proportion of NKp30, NKp46, NKG2D, and DNAM-1 expressing NK cells. Furthermore, TGF-β1 significantly downregulated the expression of NKp30, NKp46, NKG2D, and DNAM-1 on NK cells in vitro, and the addition of galunisertib, an inhibitor of the TGF-β receptor subunit I, reversed this downregulation. Altogether, our data suggest that the decreased expression of activating receptors NKp30, NKp46, NKG2D, and DNAM-1 on peripheral blood NK cells is positively associated with GC progression, and that TGF-β1-mediated NK cell suppression may be a therapeutically targetable characteristic of GC.http://dx.doi.org/10.1155/2018/6248590
spellingShingle Bin Han
Fang-yuan Mao
Yong-liang Zhao
Yi-pin Lv
Yong-sheng Teng
Mubing Duan
Weisan Chen
Ping Cheng
Ting-ting Wang
Zhong-yuan Liang
Jin-yu Zhang
Yu-gang Liu
Gang Guo
Quan-ming Zou
Yuan Zhuang
Liu-sheng Peng
Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
Journal of Immunology Research
title Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
title_full Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
title_fullStr Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
title_full_unstemmed Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
title_short Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
title_sort altered nkp30 nkp46 nkg2d and dnam 1 expression on circulating nk cells is associated with tumor progression in human gastric cancer
url http://dx.doi.org/10.1155/2018/6248590
work_keys_str_mv AT binhan alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT fangyuanmao alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT yongliangzhao alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT yipinlv alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT yongshengteng alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT mubingduan alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT weisanchen alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT pingcheng alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT tingtingwang alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT zhongyuanliang alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT jinyuzhang alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT yugangliu alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT gangguo alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT quanmingzou alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT yuanzhuang alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer
AT liushengpeng alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer